These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 18783368)

  • 1. Effects of hypocretin (orexin) neuronal loss on sleep and extracellular adenosine levels in the rat basal forebrain.
    Murillo-Rodriguez E; Liu M; Blanco-Centurion C; Shiromani PJ
    Eur J Neurosci; 2008 Sep; 28(6):1191-8. PubMed ID: 18783368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypocretin/orexin antagonism enhances sleep-related adenosine and GABA neurotransmission in rat basal forebrain.
    Vazquez-DeRose J; Schwartz MD; Nguyen AT; Warrier DR; Gulati S; Mathew TK; Neylan TC; Kilduff TS
    Brain Struct Funct; 2016 Mar; 221(2):923-40. PubMed ID: 25431268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypocretin-2 saporin lesions of the ventrolateral periaquaductal gray (vlPAG) increase REM sleep in hypocretin knockout mice.
    Kaur S; Thankachan S; Begum S; Liu M; Blanco-Centurion C; Shiromani PJ
    PLoS One; 2009 Jul; 4(7):e6346. PubMed ID: 19623260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypocretin-2-saporin lesions of the lateral hypothalamus produce narcoleptic-like sleep behavior in the rat.
    Gerashchenko D; Kohls MD; Greco M; Waleh NS; Salin-Pascual R; Kilduff TS; Lappi DA; Shiromani PJ
    J Neurosci; 2001 Sep; 21(18):7273-83. PubMed ID: 11549737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of hypocretin-saporin injections into the medial septum on sleep and hippocampal theta.
    Gerashchenko D; Salin-Pascual R; Shiromani PJ
    Brain Res; 2001 Sep; 913(1):106-15. PubMed ID: 11532254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of saporin-induced lesions of three arousal populations on daily levels of sleep and wake.
    Blanco-Centurion C; Gerashchenko D; Shiromani PJ
    J Neurosci; 2007 Dec; 27(51):14041-8. PubMed ID: 18094243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wake-promoting and sleep-suppressing actions of hypocretin (orexin): basal forebrain sites of action.
    España RA; Baldo BA; Kelley AE; Berridge CW
    Neuroscience; 2001; 106(4):699-715. PubMed ID: 11682157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between CSF hypocretin levels and hypocretin neuronal loss.
    Gerashchenko D; Murillo-Rodriguez E; Lin L; Xu M; Hallett L; Nishino S; Mignot E; Shiromani PJ
    Exp Neurol; 2003 Dec; 184(2):1010-6. PubMed ID: 14769395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A1 receptor mediated adenosinergic regulation of perifornical-lateral hypothalamic area neurons in freely behaving rats.
    Rai S; Kumar S; Alam MA; Szymusiak R; McGinty D; Alam MN
    Neuroscience; 2010 Apr; 167(1):40-8. PubMed ID: 20109537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of lateral hypothalamic lesion with the neurotoxin hypocretin-2-saporin on sleep in Long-Evans rats.
    Gerashchenko D; Blanco-Centurion C; Greco MA; Shiromani PJ
    Neuroscience; 2003; 116(1):223-35. PubMed ID: 12535955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of rostral basal forebrain neurons promotes wakefulness and induces FOS in orexin neurons.
    Satoh S; Matsumura H; Nakajima T; Nakahama K; Kanbayashi T; Nishino S; Yoneda H; Shigeyoshi Y
    Eur J Neurosci; 2003 Apr; 17(8):1635-45. PubMed ID: 12752381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Release of hypocretin (orexin) during waking and sleep states.
    Kiyashchenko LI; Mileykovskiy BY; Maidment N; Lam HA; Wu MF; John J; Peever J; Siegel JM
    J Neurosci; 2002 Jul; 22(13):5282-6. PubMed ID: 12097478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neural substrates of awakening probed with optogenetic control of hypocretin neurons.
    Adamantidis AR; Zhang F; Aravanis AM; Deisseroth K; de Lecea L
    Nature; 2007 Nov; 450(7168):420-4. PubMed ID: 17943086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of hypocretin/orexin cell transplantation on narcoleptic-like sleep behavior in rats.
    Arias-Carrión O; Murillo-Rodríguez E
    PLoS One; 2014; 9(4):e95342. PubMed ID: 24736646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microdialysis perfusion of orexin-A in the basal forebrain increases wakefulness in freely behaving rats.
    Thakkar MM; Ramesh V; Strecker RE; McCarley RW
    Arch Ital Biol; 2001 Apr; 139(3):313-28. PubMed ID: 11330208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of cholinergic basal forebrain neurons in adenosine-mediated homeostatic control of sleep: lessons from 192 IgG-saporin lesions.
    Kalinchuk AV; McCarley RW; Stenberg D; Porkka-Heiskanen T; Basheer R
    Neuroscience; 2008 Nov; 157(1):238-53. PubMed ID: 18805464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The development of hypocretin (orexin) deficiency in hypocretin/ataxin-3 transgenic rats.
    Zhang S; Lin L; Kaur S; Thankachan S; Blanco-Centurion C; Yanagisawa M; Mignot E; Shiromani PJ
    Neuroscience; 2007 Aug; 148(1):34-43. PubMed ID: 17618058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypocretin-1 modulates rapid eye movement sleep through activation of locus coeruleus neurons.
    Bourgin P; Huitrón-Résendiz S; Spier AD; Fabre V; Morte B; Criado JR; Sutcliffe JG; Henriksen SJ; de Lecea L
    J Neurosci; 2000 Oct; 20(20):7760-5. PubMed ID: 11027239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prepro-hypocretin (prepro-orexin) expression is unaffected by short-term sleep deprivation in rats and mice.
    Terao A; Peyron C; Ding J; Wurts SW; Edgar DM; Heller HC; Kilduff TS
    Sleep; 2000 Nov; 23(7):867-74. PubMed ID: 11083595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of hypocretin-1 in 192-IgG-saporin-lesioned rats.
    Blanco-Centurion CA; Shiromani A; Winston E; Shiromani PJ
    Eur J Neurosci; 2006 Oct; 24(7):2084-8. PubMed ID: 17067305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.